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Background: Exposure to UV radiation is associated with
cutaneous malignant melanoma (CMM). In mammalian
cells, UV radiation induces DNA damage that can be re-
paired by the nucleotide excision repair system. We designed
this case–control study to determine whether DNA repair
capacity (DRC) is associated with the risk of CMM and to
identify risk factors that may interact biologically with DRC
in the development of melanoma. Methods: Global DRC was
measured in lymphocytes with the host-cell reactivation as-
say. Data were analyzed by use of multiple regression mod-
els. All statistical tests were two-sided. Results: DRC could be
determined for 132 case patients with incident melanoma
and for 145 age- and sex-matched control subjects. No sta-
tistically significant association between melanoma risk and
DRC by itself was found (odds ratio [OR] = 1.0; 95% con-
fidence interval [CI] = 0.6 to 1.7, adjusted for age, sex, lym-
phocyte viability, and sample storage time). DRC, however,
strongly influenced CMM risk in individuals with a low tan-
ning ability or dysplastic nevi. Individuals with a low tanning
ability and a low DRC had a higher risk for CMM (OR = 8.6;
95% CI = 2.7 to 27.5) than individuals with a higher tanning
ability and a high DRC. Likewise, individuals with dysplastic
nevi and a low DRC had a higher relative risk (OR = 6.7;
95% CI = 2.4 to 18.6) than those lacking dysplastic nevi and
having a high DRC. Subjects with dysplastic nevi and a high
DRC had an intermediate risk. A likelihood-ratio test gave
statistically significant interactions between DRC and tan-
ning response (P = .001) and between DRC and dysplastic
nevus status (P = .04), which were independently associated
with CMM risk. Conclusions: DRC may modify the risk for
melanoma in the presence of other strong risk factors, such
as a low tanning ability and the presence of dysplastic nevi.
The occurrence of melanoma in subjects without these risk
factors appears to be independent of DRC. [J Natl Cancer
Inst 2002;94:94–101]
The incidence of and mortality from cutaneous malignant
melanoma (CMM) in Caucasians have increased rapidly
throughout the world in recent decades (1–3). A family history
of CMM, the presence of dysplastic nevi or atypical nevi, the
number of nevi, skin sensitivity to sun, freckling, and fair hair,
eye, and skin colors are known risk factors for melanoma (4).
Although sunlight exposure (5), particularly intermittent expo-
sure (6), has been associated with CMM (7), mechanisms of
UV radiation-induced carcinogenesis are still largely unknown.
UV radiation primarily leads to the formation of cyclobutane
pyrimidine dimers and 6–4 photoproducts in DNA, and forma-
tion of photoproducts has been associated with skin carcinogen-
esis (8,9). In mammalian cells, UV photoproducts are repaired
by the nucleotide excision repair system (10,11). Individuals
with inherited defects in excision repair mechanisms (e.g., pa-
tients with xeroderma pigmentosum) are at extremely high risk
of skin cancers, including melanoma (12,13).
We conducted a case–control study to determine whether the
capacity to repair UV radiation-damaged DNA, as measured by
the host-cell reactivation assay (14) in peripheral blood lympho-
cytes, was associated with the risk of CMM and to identify host
risk factors that may interact biologically with DNA repair ca-
pacity (DRC) to affect CMM risk.
SUBJECTS AND METHODS
Participants
During the period from December 1994 to January 1999, 183
case patients with incident CMM (of any stage) and 179 control
subjects were recruited at the Dermatology Unit of the Bufalini
Hospital in Cesena, Italy. In the study period, the Bufalini Hos-
pital examined approximately 85% of all CMM patients from
Affiliations of authors: M. T. Landi, M. A. Tucker (Genetic Epidemiology
Branch), R. E. Tarone (Biostatistics Branch), Division of Cancer Epidemiology
and Genetics, National Cancer Institute, Bethesda, MD; A. Baccarelli, Genetic
Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National
Cancer Institute, and Epidemiology Research Center, University of Milan, Italy;
A. Pesatori, Epidemiology Research Center, University of Milan; M. Hedayati,
L. Grossman, Department of Biochemistry, Bloomberg School of Public Health,
The Johns Hopkins University, Baltimore, MD.
Correspondence to: Maria Teresa Landi, M.D., Ph.D., National Institutes of
Health, 6120 Executive Blvd., EPS 7114, Bethesda, MD 20892–7236 (e-mail:
landim@mail.nih.gov).
See “Notes” following “References.”
© Oxford University Press
94 ARTICLES Journal of the National Cancer Institute, Vol. 94, No. 2, January 16, 2002
 at U
niversity degli Studi M
ilano on Septem
ber 6, 2012
http://jnci.oxfordjournals.org/
D
ow
nloaded from
 
the Northern Marche and Southern Romagna areas, as verified
with the Romagna region cancer registry (15) and with records
of melanoma diagnoses from the main hospitals of the area. Of
the 179 control subjects, 134 were spouses or close friends of the
case patients, 14 were outpatients referred to the hospital be-
cause of minor accidental trauma, and 31 were healthy volun-
teers from the Bufalini Hospital personnel. Control subjects
were frequency-matched to case patients by decade of age and
sex. All of the control subjects were from the same geographic
area as the case patients. The control group of hospital personnel
had a statistically significantly lower DRC (P  .01) and a
higher cell viability (P  .001) than other control groups, but no
other major differences were observed. Approximately 95% of
the case patients and 83% of the control subjects agreed to
participate in the study. Three case patients and two control
subjects reported a first-degree relative with melanoma and were
excluded from the analysis. Study subjects included 183 case
patients (87 males and 96 females) and 179 control subjects (89
males and 90 females) ranging in age from 17 years to 77 years.
After approval of the study by the Bufalini Hospital’s Ethical
Committee, written informed consent was obtained from all of
the participants. A standardized in-person questionnaire was ad-
ministered by trained interviewers, who asked questions on life-
time residential history, exposure to UV radiation, medical and
family history of cancer and other diseases, smoking habits, drug
consumption, skin reaction to the first half an hour of sun ex-
posure, tanning ability, and sunscreen use.
Tanning ability was ascertained through the following ques-
tion: “After repeated and prolonged exposure to sunlight, your
skin 1) becomes very tanned, 2) becomes medium tanned, 3)
becomes hardly tanned, 4) has a tendency to peel, or 5) has
absolutely no change.” Because no one selected choice 4 and
only three selected choice 5, the answers were categorized into
three groups: high tanning response (choice 1), medium tanning
response (choice 2), and low tanning response (choices 3 and 5).
The same dermatologist examined all of the subjects in the
study. This dermatologist examined the entire skin of each sub-
ject’s body, except for the genital area, to assess pigmentation
characteristics, freckling, and the presence of skin lesions or
other skin cancers.
An expert oncologist, blinded to melanoma status, assessed
all diagnoses of dysplastic nevi and counted the number of nevi
in standardized photographs of the back of each subject. Nevus
count was missing in two subjects because pictures did not in-
clude the entire back. Diagnosis of dysplastic nevi was uncertain
in seven subjects; thus, dysplastic nevi were recorded as miss-
ing. Fourteen subjects lacked photographs and were excluded
from the analyses in which dysplastic nevi or number of nevi
were considered. The restriction of the nevus count to the back
was necessary for feasibility reasons. A very high correlation (r
 .82 in female Caucasians, and r  .90 in male Caucasians)
between the number of nevi on a subject’s trunk and the number
of nevi on his or her entire body has been shown previously (16).
Recognition and classification of nevi and dysplastic nevi from
photographs have been shown to be accurate and reproducible
(17,18). To be defined as dysplastic, a nevus had to be 5 mm or
larger, had to be predominantly flat, and had to have at least two
of the following criteria: variable pigmentation, indistinct bor-
ders, and irregular outline (19). Nevi (4,20,21) and dysplastic
nevi (4,22) tend to disappear with age, making their diagnosis
difficult to assess in older individuals (4). We, thus, excluded
subjects (34 case patients and 15 control subjects) older than 60
years from all of the analyses that included dysplastic nevi and
nevi.
DNA Repair Assay
DRC was measured in cryopreserved lymphocytes by the
host-cell reactivation assay, as described by Athas et al. (14).
Blood samples were stored before analysis for 2–30 months. All
of the analyses were performed blinded to the case status.
Briefly, plasmid DNA containing a chloramphenicol acetyltrans-
ferase (CAT) reporter gene was UV irradiated (254 nm at 0, 350,
and 700 J/m2) before transfection. Peripheral blood lympho-
cytes, incubated for 72 hours with phytohemagglutinin, were
then transfected with undamaged or UV radiation-damaged plas-
mid DNA. The amount of plasmid used in the assay was opti-
mized and validated previously (14). Cells were incubated for
another 40 hours to allow the repair of damaged genes in the
plasmid, including the CAT gene. Gene expression was then
measured as CAT activity, expressed as counts per minute (cpm)
of [3H]acetylchloramphenicol. DRC was calculated as the per-
centage of residual CAT gene expression after the repair of UV
radiation-damaged plasmid DNA divided by that in undamaged
plasmid DNA (100%). The background level of CAT activity
was approximately 200 cpm. Xeroderma pigmentosum D (XPD)
and xeroderma pigmentosum A (XPA) cells were used as posi-
tive controls. After 254-nm irradiation at 350 J/m2, the repair
activity was about 2% in XPD cells and 0.8% in XPA cells.
After irradiation at 700 J/m2, DRC was about 0.7% in XPD and
0.3% in XPA.
Each sample was assayed twice, and a very high correlation
was observed between the two repeats (r  .89 for CAT activity
at baseline level, r  .91 after irradiation with 350 J/m2, and r
 .88 after irradiation with 700 J/m2). Results reported reflect
the average of the two repeats. DRC was measured from nine to
12 times in three control samples (one primary cell sample from
a healthy volunteer, one cell line from a healthy subject, and one
xeroderma pigmentosum C [XPC] cell line, whose DRC is in-
termediate between XPD DRC and that of healthy individuals
[after irradiation at 350 J/m2, DRC is about 9.8%, and after
irradiation at 700 J/m2, DRC is about 1%]) to assess the assay’s
reproducibility among different batches. DRC after irradiation
with 350 J/m2 had a lower coefficient of variation than DRC
after irradiation with 700 J/m2 (27.8% versus 51.7%, respec-
tively) in these three samples. In all of the analyses, results based
on DRC values measured after irradiation with 350 and 700 J/m2
were very similar. Consequently, we report only results obtained
after irradiation with 350 J/m2. Cell viability, baseline CAT
activity, and blastogenic rate were similar in subjects recruited in
different seasons. CAT activity of less than 1000 cpm in unir-
radiated cells is required to accurately measure DRC with a
signal-to-noise ratio at least twofold higher than the background
level (200 cpm) in cells with irradiated plasmids. Therefore,
subjects with baseline CAT activity of less than 1000 cpm (51
[27.9%] of 183 case patients and 34 [19.0%] of 179 control
subjects) were excluded from the analysis. Thus, we analyzed
data from 132 case patients and from 145 age- and sex-matched
control subjects. The mean age was slightly higher (P  .03) in
the excluded subjects (mean ± standard deviation [SD]  50.4
± 14.8 years) than in those included in the study (46.2 ± 14.1
years). No other statistically significant differences were found
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between the two groups. The characteristics of the entire group
of 183 case patients and 179 control subjects were reported
elsewhere (23). Baseline and induced CAT activities are re-
ported in Table 1. In subjects (n  59) with a baseline CAT
activity between 1000 and 5000 cpm, DRC levels had statisti-
cally significantly higher variability (SD  17.2%) than in sub-
jects with a CAT activity of more than 5000 cpm (SD  8.8%)
(P<.001, test on equality of variances).
Statistical Analysis
Adjusted odds ratios (ORs), 95% confidence intervals (CIs),
and tests for trend were computed by use of multiple logistic
regression models, including matching variables (i.e., age and
sex) as independent variables. Cell viability and length of
sample storage were slightly associated with case status (median
cell viability  69.9% in case patients and 73.7% in control
Table 1. Characteristics of study subjects and risk of CMM*
Case patients
(n  132)
Control subjects
(n  145)
Adjusted for age and sex
Adjusted for age, sex,
and host characteristics‡
OR for CMM
(95% CI)
P for
trend†
OR for CMM
(95% CI)
P for
trend†
Sex, No. (%)
Males 63 (47.7) 75 (51.7)
Females 69 (52.3) 70 (48.3)
Mean age, y (±SD) 48.0 (±15.0) 44.6 (±12.9)
Mean CAT activity, cpm × 1000 (95% CI)
Baseline 21.6 (17.7 to 25.5) 23.2 (19.3 to 27.1)
350 J/m2 4.5 (3.7 to 5.3) 4.7 (3.8 to 5.7)
700 J/m2 1.5 (1.2 to 1.7) 1.6 (1.2 to 2.0)
Hair color, No. (%)§
Black 8 (6.2) 23 (16.2) 1.0 (referent) 1.0 (referent)
Dark brown 64 (49.2) 79 (55.6) 3.0 (1.2 to 7.5) 2.2 (0.7 to 6.9)
Light/reddish brown 38 (29.2) 33 (23.2) 4.5 (1.7 to 12.3) 2.1 (0.6 to 7.1)
Blond 18 (13.9) 7 (4.9) 9.9 (2.8 to 34.9) 2.6 (0.6 to 12.2) .270
Red 2 (1.5) 0 (0) — <.001 —
Eye color, No. (%)
Dark 32 (24.2) 61 (42.1) 1.0 (referent) 1.0 (referent)
Medium 72 (54.6) 72 (49.7) 2.0 (1.2 to 3.6) 1.9 (1.0 to 3.5)
Light 28 (21.2) 12 (8.3) 4.8 (2.1 to 10.9) <.001 4.4 (1.7 to 11.3) .002
Skin color, No. (%)§
Dark/olive 3 (2.3) 22 (15.2) 1.0 (referent) 1.0 (referent)
Medium 52 (39.7) 74 (51.0) 4.3 (1.2 to 15.3) 2.7 (0.7 to 11.2)
Light 76 (58.0) 49 (33.8) 10.4 (2.9 to 37.1) <.001 4.3 (1.0 to 18.8) .039
Freckles, No. (%)§
No 55 (42.0) 74 (51.7) 1.0 (referent) 1.0 (referent)
Yes 76 (58.0) 69 (48.3) 1.5 (0.9 to 2.5) 1.0 (0.5 to 1.8)
Tanning ability after prolonged sun exposure, No. (%)§
High 21 (16.4) 52 (36.9) 1.0 (referent) 1.0 (referent)
Medium 62 (48.4) 71 (50.4) 2.0 (1.1 to 3.7) 1.1 (0.5 to 2.4)
Low 45 (35.2) 18 (12.8) 6.0 (2.8 to 12.9) <.001 3.4 (1.3 to 8.7) .009
Skin response to 30 min in the sun, No. (%)§
Tan without burn 31 (24.2) 53 (37.3) 1.0 (referent) 1.0 (referent)
Light/medium burn 63 (49.2) 67 (47.2) 1.6 (0.9 to 2.8) 1.1 (0.6 to 2.2)
Severe burn/blistering 34 (26.6) 22 (15.5) 3.0 (1.5 to 6.2) .003 1.1 (0.4 to 2.5) .868
Dysplastic nevi, No. (%)§,¶
No 44 (48.9) 96 (82.1) 1.0 (referent) 1.0 (referent)
Yes 46 (51.1) 21 (17.9) 5.0 (2.6 to 9.6) 4.3 (2.1 to 8.9)
Nevi, No. (%)§,¶
0–20 14 (15.7) 44 (35.8) 1.0 (referent) 1.0 (referent)
20–40 29 (32.6) 38 (30.9) 2.7 (1.2 to 6.0) 2.1 (0.8 to 5.4)
40–190 46 (51.7) 41 (33.3) 4.2 (2.0 to 9.1) <.001 2.2 (0.8 to 5.9) .135
Sunburns with blisters, No. in lifetime (%)
None 108 (81.8) 121 (83.4) 1.0 (referent) 1.0 (referent)
1–5 13 (9.9) 20 (13.8) 0.8 (0.4 to 1.6) 0.7 (0.3 to 1.7)
>5 11 (8.3) 4 (2.8) 3.5 (1.0 to 11.5) .192 1.8 (0.5 to 7.1) .814
*CMM  cutaneous malignant melanoma; OR  odds ratio; CI  confidence interval; SD  standard deviation; cpm  counts per minute.
†Test for trend across classes.
‡ORs and 95% CIs adjusted for age, sex, eye color, skin color, tanning ability after prolonged sun exposure, and presence of dysplastic nevi.
§Total number of subjects may vary across variables because of missing values.
Low risk  black or dark brown; medium risk  light brown, brown–green, green, or blue–green; high risk  light blue, dark blue, or gray.
¶Subjects older than 60 years of age were excluded from the analysis. All statistical tests are two-sided.
96 ARTICLES Journal of the National Cancer Institute, Vol. 94, No. 2, January 16, 2002
 at U
niversity degli Studi M
ilano on Septem
ber 6, 2012
http://jnci.oxfordjournals.org/
D
ow
nloaded from
 
subjects, P  .05; median storage length  8.5 months in case
patients and 6.0 months in control subjects, P  .09) and with
DRC (correlation between DRC and viability, rs  –.26
[P<.001]; correlation between DRC and sample storage length,
rs  .11 [P  .07]). Thus, all of the analyses that included DRC
were adjusted for both cell viability and length of sample stor-
age. Results shown throughout this article were not adjusted by
baseline CAT activity and blastogenic rate because these vari-
ables were associated with neither DRC nor case status, and their
inclusion in the analyses did not change the results. The presence
of statistically significant interactions among variables in the
models was tested by use of a likelihood-ratio test. Forward
stepwise regression analysis was used to identify the strongest
risk factors for CMM risk. Likelihood-ratio 2 (LRX) was used
to select the most statistically significant factors to be added to
the initial logistic model. Variables with a P value of less than
.05 entered the model; those with a P value of .10 or more were
removed from the model. Wilcoxon (Mann–Whitney) rank-sum
and Kruskal–Wallis tests were used for single-group and mul-
tiple-group comparisons, respectively. Proportions were com-
pared by use of Fisher’s exact test. Spearman rank correlation
statistics was used to test for linear correlation between vari-
ables. All statistical tests were two-sided. Results are not strati-
fied by sex because they were similar in the two sexes. All of the
analyses were performed by use of the Stata statistical package
(release 6.0; Stata Corporation, College Station, TX).
RESULTS
Subject Characteristics
The personal characteristics of the 132 case patients with
CMM and of the 145 control subjects for whom DRC could be
determined are shown in Table 1. In order of relative statistical
significance, the strongest risk factors for CMM identified by
stepwise regression analyses were the presence of dysplastic
nevi (LRX  26.5; P<.001) and a tanning response after
prolonged sun exposure (LRX  18.2; P<.001). Eye color and
skin color were lower predictors of CMM risk (LRX  11.5
[P  .003] and LRX  7.7 [P  .022], respectively).
DRC by Subject Characteristics
The median DRC values by sex, age, tanning ability, and sun
exposure are shown in Table 2, stratified by case status, the
presence of dysplastic nevi, and the number of nevi (<35 nevi
versus 35 nevi). DRC decreased with age in control subjects
lacking dysplastic nevi (P  .05) or with few nevi (P  .05)
but increased with age in control subjects with dysplastic nevi
(P  .02) or with many nevi (P  .24). There was no association
Table 2. Median DNA repair capacity (DRC)* after 254-nm UV irradiation (350 J/m2) by subjects’ characteristics
Case patients† Control subjects†
All DN negative DN positive <35 nevi 35 nevi All DN negative DN positive <35 nevi 35 nevi
No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC No.
Median
DRC
All subjects 132 19.1 44 20.2 46 18.8 34 18.8 55 20.5 145 18.4 96 18.6 21 20.1 72 17.9 51 19.8
Sex
Males 63 19.1 22 20.2 19 19.7 13 19.0 27 21.0 75 18.5 49 19.8 14 19.6 32 17.9 34 20.3
Females 69 18.4 22 20.2 27 17.3 21 18.4 28 19.8 70 18.3 47 18.3 7 20.3 40 17.8 17 19.7
Age, y
17–40 42 19.4 18 21.0 22 19.1 17 19.0 22 20.2 57 19.6 43 19.9 11 18.5 33 19.6 22 19.1
40–55 41 18.3 18 16.6 19 19.1 14 15.7 23 19.7 54 18.0 39 17.2 7 20.3 29 17.2 21 19.2
55–77 49 19.6 8 25.9 5 17.4 3 19.8 10 20.9 34 17.6 14 15.6 3 32.4 10 13.4 8 23.5
P  .05‡ P  .02‡ P  .05‡
Tanning ability
after prolonged
sun exposure
High/medium 83 19.8 28 20.3 27 21.0 18 20.9 36 20.9 123 17.6 83 17.7 18 20.2 63 17.3 42 18.8
Low 45 17.3 15 19.8 19 16.5 15 16.8 19 16.7 18 24.0 10 24.0 2 26.1 7 20.9 7 26.9
P  .04§ P  .02§ P  .04§ P  .03§
Cumulative inter-
mittent sun
exposure, h
0–200 47 17.0 10 20.6 15 15.4 9 19.8 15 15.4 40 18.9 30 18.9 3 24.0 24 18.5 12 22.0
200–1500 44 17.9 18 18.5 14 20.3 14 17.5 18 20.7 43 17.3 26 17.1 8 18.8 22 17.3 16 18.4
1500–20 000 35 23.1 15 27.3 15 21.0 10 25.9 20 21.9 54 19.4 34 18.8 9 21.7 23 19.1 19 19.8
P  .01 P  .05 P  .03
*DRC was calculated as the percentage of residual chloramphenicol acetyltransferase gene expression after the repair of UV radiation-damaged plasmid DNA
divided by that in undamaged plasmid DNA (100%).
†Total number of subjects may vary because of missing values. Nevus count is missing in two subjects because pictures did not include the entire back. Dysplastic
nevus (DN) diagnosis was uncertain in seven subjects; thus, DN was recorded as missing. Fourteen subjects who lacked photographs and 49 subjects older than
60 years were excluded from the analyses with DN and number of nevi; thus, the total number of subjects in these categories is lower than the total number of case
patients and control subjects. Approximately 83% of subjects with DN also had 35 or more nevi, and 66% of subjects without DN had fewer than 35 nevi. Age and
sun exposure categories were approximately based on tertiles. All statistical tests are two-sided.
‡Spearman rank correlation test for the association between DRC and age.
§Wilcoxon (Mann–Whitney) rank-sum test for differences between high/medium versus low tanning ability.
Spearman rank correlation test for the association between DRC and recreational sun exposure.
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between DRC and age in the case group. When subjects were
stratified by tanning ability (medium/high versus low), no asso-
ciation between DRC and age was observed (data not shown).
Among control subjects, those with a lower tanning ability had
a higher DRC. Among case patients, there was no substantive
difference in DRC by tanning ability, except an inverse statis-
tically significant association in those with dysplastic nevi.
Among case patients, DRC was positively associated with
recreational lifetime sun exposure (between 11 AM and 3 PM)
(P .01), particularly in those with dysplastic nevi (P .05 for
case patients with dysplastic nevi, and P  .09 for case patients
without dysplastic nevi). No association was found between
DRC and melanoma characteristics, including histologic sub-
types (P .39), thickness (P .70), or Clark’s level (P .71).
No statistically significant association was observed in all
study subjects between DRC and hair color (P  .49), eye color
(P  .72), skin color (P  .20), freckles (P  .39), propensity
to tan after prolonged sun exposure (P  .29), skin response
after the first 30 minutes in the sun (P  .98), use of photosen-
sitizing drugs (P  .72), vitamin intake (P  .96), or smoking
exposure (P  .28).
Sun Exposure and CMM Risk
The majority of subjects (57% of case patients and 59% of
control subjects) did not work outside, and occupational sun
exposure was not associated with CMM risk. Many subjects
reported prolonged recreational (intermittent) sun exposure,
which differed slightly between case patients and control sub-
jects (P  .15, test for trend for exposure categories, after ad-
justing for age, sex, and pigmentation characteristics). Among
control subjects, cumulative intermittent sun exposure did not
differ by dysplastic nevus status (P  .37).
CMM Risk by DRC
Overall, we found no statistically significant association be-
tween CMM risk and DRC (OR  1.0 [95% CI  0.6 to 1.7],
adjusted for age, sex, cell viability, and storage length) (Table 3).
We then evaluated the two strongest melanoma risk factors,
tanning ability and dysplastic nevi (Table 4), and found that
DRC strongly influenced CMM risk in individuals with a low
tanning ability or dysplastic nevi. Subjects with both a low DRC
and a low tanning ability had an OR for CMM of 8.6 (95% CI
 2.7 to 27.5) compared with subjects with a high DRC and a
high/medium tanning ability. The joint effect of DRC and tan-
ning ability was much larger than the sum of the individual
effects (i.e., there was an interaction) in the logistic regression
equation (P  .001). Among subjects with a low tanning ability,
those with a low DRC had a fivefold higher relative risk of
melanoma (OR  4.9 [95% CI  1.4 to 17.3], adjusted for age
and sex) than those with a high DRC.
Subjects with both a low DRC and dysplastic nevi had a
higher relative risk for CMM (OR 6.7; 95% CI 2.4 to 18.6)
than subjects without dysplastic nevi and with a high DRC.
Subjects with dysplastic nevi and a high DRC had an interme-
diate relative risk (OR  2.9; 95% CI  1.2 to 6.7). Among
subjects with dysplastic nevi, those with a low DRC had an OR
for CMM of 1.9 (95% CI  0.6 to 5.8, adjusted for age and sex)
compared with subjects with a high DRC. Results were similar
in subjects with a high number of nevi (data not shown). The test
for interaction between DRC and dysplastic nevus status was
marginally statistically significant (P  .04).
Only two control subjects had both dysplastic nevi and a low
tanning ability. When the model for CMM relative risk associ-
ated with tanning ability and DRC was adjusted for the presence
Table 3. Risk of cutaneous malignant melanoma (CMM) by DNA repair capacity (DRC)*
DRC, %
No. of
case patients
No. of
control subjects
CMM relative risk
Adjusted for age and sex
(n  277)
Adjusted for
laboratory varaiables†
(n  277)
Adjusted for laboratory variables
and host characteristics‡
(n  201)§
OR 95% CI OR 95% CI OR 95% CI
18.4 64 73 0.9 0.5 to 1.4 1.0 0.6 to 1.7 1.0 0.5 to 2.0
>18.4 68 72 1.0 Referent 1.0 Referent 1.0 Referent
*DRC above or below the median value (18.4%) in control subjects, after 254-nm UV irradiation at 350 J/m2. OR  odds ratio; CI  confidence interval.
†OR and 95% CI adjusted for age, sex, cell viability, and storage length.
‡OR and 95% CI adjusted for age, sex, cell viability, storage length, skin color, eye color, propensity to tan after prolonged sun exposure, and presence of
dysplastic nevi.
§Subjects older than 60 years and/or missing values were excluded from the analysis.
Table 4. Risk of cutaneous malignant melanoma (CMM) and DNA repair
capacity (DRC), by tanning ability after prolonged sun exposure and presence
of dysplastic nevi (DN)
No. of
case patients
No. of
control subjects OR (95% CI)*
DRC† Tanning ability
Low Low 26 4 8.6‡ (2.7 to 27.5)
High Low 19 14 1.5‡ (0.6 to 3.5)
Low High/medium 35 68 0.6‡ (0.3 to 1.1)
High High/medium 48 55 1.0‡ (referent)
DRC† DN§
Low Positive 23 7 6.7 (2.4 to 18.6)
High Positive 23 14 2.9 (1.2 to 6.7)
Low Negative 17 47 0.6 (0.2 to 1.3)
High Negative 27 49 1.0 (referent)
*Odds ratios (ORs) and 95% confidence intervals (CIs) adjusted for age, sex,
cell viability, and storage length.
†DRC above or below the median value (18.4%) in control subjects, after
254-nm UV irradiation at 350 J/m2.
‡Likelihood-ratio test for the interaction between DRC and tanning ability:
P  .001.
§Subjects older than 60 years were excluded from the analysis.
Likelihood-ratio test for the interaction between DRC and presence of DN:
P  .04. All statistical tests are two-sided.
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of dysplastic nevi, the ORs did not substantially change (OR 
14.5 [95% CI  2.9 to 73.6] for subjects with a low DRC and
a low tanning ability; OR  2.3 [95% CI  0.8 to 6.6] for
subjects with a high DRC and a low tanning ability; OR  0.6
[95% CI  0.3 to 1.3] for subjects with a low DRC and a
high/medium tanning ability). Similarly, when the model for
CMM risk associated with the presence of dysplastic nevi and
DRC was adjusted for tanning ability, the ORs did not change
substantially (OR  6.7 [95% CI  2.2 to 20.6] for subjects
with a low DRC and dysplastic nevi; OR  3.3 [95% CI  1.3
to 8.1] for subjects with a high DRC and dysplastic nevi; OR 
0.6 [95% CI  0.3 to 1.5] for subjects with a low DRC but
without dysplastic nevi). Thus, interactions between DRC and
the tanning response and between DRC and the dysplastic nevus
status were independently associated with CMM risk.
No association between sun exposure (above or below 700
cumulative peak hours of intermittent exposure during lifetime)
and CMM risk by DRC levels was observed (data not shown).
CMM Risk in Subgroups
In the subset of 218 individuals with a CAT activity of greater
than 5000 cpm, the findings were comparable to those obtained
in the larger study group. When the hospital volunteers and
subjects with minor trauma from the control group were ex-
cluded and then all of the analyses were repeated, the results
were not substantially different from those reported throughout
this article. Of note, in the subset of subjects with a basal CAT
activity of more than 5000 cpm and with only case spouses or
friends as control subjects, the relative risk for CMM in people
with a low DRC and a low tanning ability was even stronger than
that in the entire dataset after adjustment for age, sex, length of
sample storage, and cell viability (OR  20.1 [95% CI  2.5 to
162.8]; P  .002, test for interaction between DRC and tanning
ability). In the same subset (but with individuals <60 years old),
subjects with a low DRC and dysplastic nevi had an OR for
CMM of 8.3 (95% CI  2.0 to 35.0), and the interaction
between dysplastic nevi and DRC was statistically significant
(P  .006).
DISCUSSION
Human subjects typically display a range of inherent sensi-
tivities to sunlight exposure, possibly because of differences in
skin pigmentation and in the ability to repair DNA damage. The
highest world’s rates of CMM are in Australia, where a largely
Celtic population inhabits a subtropical zone (24). In Europe,
CMM rates tend to be lower in southern countries (25), where
high levels of UV radiation are present and relatively dark skin
predominates. CMM may be caused by intermittent exposure of
nonacclimatized Caucasian skin to sunlight, which may result in
repeated burning (6,26,27). In contrast, continuous sun exposure
able to induce persistent tanning in those who tan well may be
somewhat protective against melanoma (28). CMM relative risk
may increase proportionally to the dose received by nontanned
skin (27) and to the capacity of that skin to repair sunlight-
induced DNA damage. We found similar DNA repair profi-
ciency in subjects with and without melanoma; thus, the inherent
capacity to repair DNA damage did not affect overall CMM risk
(Table 3). However, among subjects with a low tanning ability
or with dysplastic nevi, the relative risk of melanoma was sta-
tistically significantly modified by DRC (Table 4).
The finding that tanning ability statistically interacts with
DRC in its association with the relative risk of melanoma is
supported by data on melanin and its association with DNA
damage (29–31). Two distinct types of melanin are present in
human skin: the red–yellow pheomelanin and the brown–black
eumelanin. The presence of eumelanin corresponds to the sun
sensitivity of skin: the higher the concentration of eumelanin, the
lower the sun sensitivity (29). Pheomelanin protects skin less
well against UV radiation-induced damage (30) and may gen-
erate free radicals on exposure to UV radiation (31). Although
the association among pigmentation characteristics, such as hair
color, and the density and type of melanin is still under study
(32), DNA repair proficiency may be of great importance in
subjects with a poor tanning response, who have an increased
propensity to DNA damage and an increased relative risk of
CMM (Table 1). Indeed, in our study, the relative risk of CMM
was nine times higher in subjects with both a low tanning ability
and a low DRC than in subjects with a high/medium tanning
ability and a high DRC (Table 4). We did not find a similar
interaction with other pigmented characteristics, such as the
color of skin, eyes, or hair, perhaps because these variables were
less strongly associated with melanoma than the presence of
dysplastic nevi and tanning ability, as shown by the forward
stepwise regression analysis.
The risk of melanoma associated with dysplastic nevi appears
to be modified by DRC. Subjects at an increased risk of mela-
noma because of dysplastic nevi had an even higher risk when
poor DRC was present. The incremental risk associated with a
low DRC appears somewhat lower among individuals with dys-
plastic nevi than among those with a low tanning ability. The
effects of dysplastic nevi and tanning ability on CMM risk
seemed to be independent.
Dysplastic nevi are recognized risk factors for and precursor
lesions of melanoma. In individuals with dysplastic nevi, a low
DRC may result in higher mutation rates and, consequently, in
increased rates of melanoma (Table 4). Indeed, studies (33,34)
on bleomycin- and x-ray-induced DNA damage in subjects with
CMM and dysplastic nevi found that patients with both CMM
and dysplastic nevi had a statistically significantly higher sen-
sitivity to mutagens than patients with only dysplastic nevi. In
contrast, no statistically significant difference in DRC was ob-
served between individuals with dysplastic nevi from mela-
noma-prone families and healthy control subjects (35).
As shown in Table 4, individuals with a low DRC and either
a high/medium tanning ability or no dysplastic nevi appeared at
somewhat lower risk than the reference groups. We, therefore,
evaluated the distribution of other risk factors. Among subjects
with a high/medium tanning ability, those with a low DRC were
less likely to have dysplastic nevi and had slightly lower sun
exposure and fewer nevi than those with a high DRC. Similarly,
among subjects without dysplastic nevi, those with a low DRC
had slightly lower sun exposure and a higher tanning ability than
those with a high DRC.
In control subjects with dysplastic nevi, DRC increased with
age. Early studies (36–38) suggested that individuals with dys-
plastic nevi may have a high genomic instability. Mammalian
cells with accumulating sublethal mutations appear to have en-
hanced DRC (39,40), and in vitro UV radiation appears to stimu-
late DNA repair activity (39). Thus, the accumulating mutations
in subjects with a high genomic instability may continuously
induce DNA repair activity, which would explain the age-
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associated elevation in DRC observed in control subjects with
dysplastic nevi. In control subjects without dysplastic nevi, DRC
decreases with age, as shown previously (41). Subjects with
dysplastic nevi and a low inducible DNA repair activity may
accumulate mutations, which, consequently, can increase their
risk of melanoma. In fact, in our study, DRC was not associated
with age in case patients, even in those with dysplastic nevi.
Sun exposure is considered to be the major environmental
risk factor for melanoma, based largely on retrospective studies
of fair-skinned populations (27). In Italy, the association be-
tween sun exposure and melanoma risk has been less consistent
(42–46). In our study, all of the subjects lived in the same
geographic area, most for their entire lifetime. In addition, be-
cause most control subjects were spouses or partners of the case
patients, these groups had a similar adult sun exposure. This
similarity with regard to sun exposure was appropriate for our
investigation. Our goal was to identify subjects at high risk for
melanoma because of their inherited characteristics, independent
of sun exposure.
We also considered potential sources of bias or confounding.
Selection bias is unlikely because we ascertained virtually all of
the case patients in the study area, we obtained a high response
rate from case patients and control subjects, and we observed
essentially no difference after exclusion of the two smaller
groups of control subjects. One dermatologist assessed the sub-
jects’ pigmentation characteristics and skin lesions. After exclu-
sion of subjects older than 60 years, one oncologist, blinded to
case status, assessed dysplastic nevus diagnoses and nevus
counts from photographs of the back of each subject. Because
dysplastic nevi tend to disappear with age, misclassification of
dysplastic nevus status in older subjects is a concern. To be
consistent and more conservative, we excluded subjects older
than 60 years, even though this exclusion reduced the sample
size. Including the entire group of subjects in the analyses, how-
ever, did not substantially change the results from those obtained
including only subjects 60 years old or younger (data not
shown).
Our investigation measured the DRC in lymphocytes with the
host-cell reactivation assay, which measures the global level of
DNA repair rather than a specific enzymatic step in the repair
process. We did not measure DRC in melanocytes because they
constitute only 5%–10% of skin cells. In a small study con-
ducted on epidermal cells after UV irradiation, Xu et al. (47)
showed no association between DRC and CMM risk, in agree-
ment with this study (Table 3). Previous studies using the same
assay on lymphocytes showed positive associations between a
low DRC and the risk of basal cell carcinoma (41), lung cancer
(48), and head and neck cancer (49). In our study, we found a
high coefficient of variation in the three samples that were as-
sessed multiple times. Two of these samples were cell lines,
which have higher variability than primary cells. In addition,
variability could reflect the fact that assays were performed in
different batches and by two different laboratory investigators
on different days. Variability was greater after a higher dose of
irradiation, as expected (50). The intrabatch correlation between
duplicate analyses, however, was very high.
The host-cell reactivation assay requires considerable techni-
cal skill and is sensitive to cell conditions. Because of their low
CAT activity, we had to exclude samples from 51 case patients
and 34 control subjects, but we observed no major differences
by subject characteristics between the excluded and included sub-
jects. Thus, a bias caused by this exclusion is unlikely. We at-
tempted to verify assay validity and to reduce random error of
measurement, as in a carefully conducted study (50), which found
no association between DRC and risk of basal cell carcinoma. Two
highly experienced laboratory scientists (M. Hedayati and
L. Grossman) performed the assay. These scientists, who were
blinded to the case status of the samples, assessed samples from
case patients and control subjects simultaneously in the same
batches. They performed every assay in duplicate. Every statis-
tical analysis that included DRC was controlled for cell viability
and length of sample storage, which were slightly associated
with case status and DRC. The results based on the UV dose
with the lowest coefficient of variation were presented. We also
found that the season during which specimens were collected or
smoking history did not affect DRC. In addition, we analyzed a
subset of individuals with optimum cell conditions (high viabil-
ity and high baseline CAT activity) to verify the study findings.
No statistically significant differences between this subset and
the entire study group were observed. If anything, the associa-
tion between DRC and CMM risk in subjects with dysplastic
nevi or with a low tanning ability was even stronger in this
subgroup.
In conclusion, our study suggests that DRC is an important
modifier of melanoma risk in the presence of other strong risk
factors, such as a low propensity to tan and the presence of
dysplastic nevi. As with all statistical interactions that are iden-
tified for the first time, replication in an independent study is
necessary. The occurrence of melanoma in subjects without dys-
plastic nevi or with a low sun sensitivity appeared to be inde-
pendent of DRC.
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